Adriamycin inhibits adipogenesis through the modulation of PPARγ and restoration of adriamycin-mediated inhibition of adipogenesis by PPARγ over-expression

References

• Altiok S, Xu M, Spiegelman BM. 1997. PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11:1987–1998.
   PubMed Web of Science ®Google Scholar
• Amri EZ, Dani C, Doglio A, Etienne J, Grimaldi P, Ailhaud G. 1986. Adipose cell differentiation: evidence for a two-step process in the polyamine-dependent Ob1754 clonal line. Biochem J 238:115–122.
   Google Scholar
• Birsoy K, Chen Z, Friedman J. 2008. Transcriptional regulation of adipogenesis by KLF4. Cell Metab 7:339–347.
   PubMed Web of Science ®Google Scholar
• Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM. 1996. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 10:974–984.
   PubMed Web of Science ®Google Scholar
• Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. 1994. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798–800.
   PubMed Web of Science ®Google Scholar
• Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. 2005. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab 1:93–106.
   PubMed Web of Science ®Google Scholar
• Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803–812.
   PubMed Web of Science ®Google Scholar
• Gregoire FM, Smas CM, Sul HS. 1998. Understanding adipocyte differentiation. Physiol Rev 78:783–809.
   PubMed Web of Science ®Google Scholar
• Grommes C, Landreth GE, Heneka MT. 2004. Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 5:419–429.
   PubMed Web of Science ®Google Scholar
• He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. 1998. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Holst D, Luquet S, Kristiansen K, Grimaldi PA. 2003. Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdifferentiation. Exp Cell Res 288:168–176.
   PubMedGoogle Scholar
• Hu E, Tontonoz P, Spiegelman BM. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 92:9856–9860.
   PubMed Web of Science ®Google Scholar
• Iliskovic N, Li T, Khaper N, Palace V, Singal PK. 1998. Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress. Mol Cell Biochem 188:161–166.
   PubMed Web of Science ®Google Scholar
• Keller H, Wahli W. 1993. Peroxisome proliferator-activated receptors A link between endocrinology and nutrition? Trends Endocrinol Metab 4:291–296.
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813–819.
   PubMed Web of Science ®Google Scholar
• Knauf C, Rieusset J, Foretz M, Cani PD, Uldry M, Hosokawa M, Martinez E, Bringart M, Waget A, Kersten S, Desvergne B, Gremlich S, Wahli W, Seydoux J, Delzenne NM, Thorens B, Burcelin R. 2006. Peroxisome proliferator-activated receptor alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain. Endocrinology 147:4067–4078.
   Google Scholar
• Lee JY, Hashizaki H, Goto T, Sakamoto T, Takahashi N, Kawada T. 2011. Activation of peroxisome proliferator-activated receptor-a enhances fatty acid oxidation in human adipocytes. Biochem Biophys Res Commun 407:818–822.
   PubMed Web of Science ®Google Scholar
• Matsusue K, Peters JM, Gonzalez FJ. 2004. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. FASEB J 18:1477–1479.
   PubMed Web of Science ®Google Scholar
• Panjrath GS, Patel V, Valdiviezo CI, Narula N, Narula J, Jain D. 2007. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model. J Am Coll Cardiol 49:2457–2464.
   PubMed Web of Science ®Google Scholar
• Sato K, Yonemura T, Ishii H, Toyomizu M, Kamada T, Akiba Y. 2009. Role of peroxisome proliferator-activated receptor beta/delta in chicken adipogenesis. Comp Biochem Physiol, Part A Mol Integr Physiol 154:370–375.
   Google Scholar
• Spiegelman BM, Green H. 1980. Control of specific protein biosynthesis during the adipose conversion of 3T3 cells. J Biol Chem 255:8811–8818.
   PubMedGoogle Scholar
• Student AK, Hsu RY, Lane MD. 1980. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255:4745–4750.
   PubMed Web of Science ®Google Scholar
• Tang QQ, Lane MD. 1999. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev 13:2231–2241.
   PubMed Web of Science ®Google Scholar
• Theocharis S, Margeli A, Vielh P, Kouraklis G. 2004. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev 30:545–554.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147–1156.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman BM. 1995. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 5:571–576.
   PubMed Web of Science ®Google Scholar
• Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Ng PC, Pong NH, Zhao H, Zhang L, Sung RY. 2009. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol 63:343–349.
   Google Scholar